Articles and Insights About Wearables for Clinical Trials

Poster

Patient-Centric Digital Endpoints of Function for AD Research

 Jen Blankenship, PhD

At the ISCTM 20th Annual Scientific Meeting, Senior Research Scientist Jen Blankenship, PhD, presented our ongoing work to understand patient perspectives on how mild AD impacts their daily life and function and identify the meaningful aspects of health that are measurable with low-burden wearable actigraphy sensors. Download the poster and read the abstract below.

Read More

VivoSense Study to Develop Digital Measures of Function for AD

 Jen Blankenship, PhD

At the a2 National Symposium: Empowering Innovation in AI/Tech + Aging, Senior Research Scientist Jen Blankenship, PhD, presented our ongoing work with the Center for Human Health and Performance at the University of Massachusetts Amherst to develop digital clinical measures that capture how patients with Alzheimer’s disease function in their real-world environments. 

Read More

Opportunities for Real-World Measures in Alzheimer's Research

 Jen Blankenship, PhD

Alzheimer’s disease (AD) is a devastating neurodegenerative disease that progresses to impact every dimension of a patient’s life. With no cure and limited options to manage symptoms, research is underway to develop drugs that impact the most burdensome aspects of AD: memory problems and the ability to function independently.

Read More
 Newer All Articles Older 

Stay Connected

Popular